Maximizing the impact of HIV prevention and treatment by bridging the gap between research and clinical practice.
ViiV Healthcare, the only company solely focused on HIV, is leading the way in HIV Implementation Science. We invest in research to bridge the gap between clinical trials and real-world HIV care, aiming to improve prevention and treatment services and outcomes.
What is Implementation Science?
Implementation Science is the study of methods to promote the integration of research findings and evidence into healthcare policy and practice. We collaborate with researchers, public health leaders, academia, governments, and community organizations to maximize the impact of implementation research.
Our implementation research projects have a global reach and focus on improving the HIV prevention and care continuum. We are dedicated to identifying strategies to bridge the gap between the availability of effective HIV medications and the access and use of those medicines to better the lives of people living with HIV and of people who can benefit from PrEP.
Digital Innovation & Implementation Science
ViiV’s Digital Innovation & Implementation Science team works together to lever research and digital solutions to transform HIV care, prevention, and experiences. Striving to lead the industry, our solutions include developing support tools, educational materials, and diagnostic innovations, all with the goal of improving experiences for patients and providers.
Read more about implementation science
Learn more what implementation science means and the challenges of implementing HIV care
NP-GBL-HVX-WCNT-220049 August 2025
Adverse events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221441.
If you are from outside the UK, you can report adverse events to GSK/ViiV by selecting your region and market, here.
